» Dr. Jerika Lam
Associate Professor, Pharmacy Practice

School of Pharmacy
Dr. Jerika Lam
Office Location:
Rinker Health Science Campus 207
Phone:
(714) 516-5479
Email:
Education
University of California, Los Angeles, Bachelor of Arts
University of Southern California, Doctor of Pharmacy
Biography

In addition to the degrees listed in the Education section above, Dr. Lam holds the following credentials: AAHIVP and FCSHP. Dr. Lam received her Bachelor of Arts degree from the University of California Los Angeles. She received her Doctor of Pharmacy degree from the University of Southern California (USC) School of Pharmacy. She completed a PGY1 residency at the San Francisco Veterans Affairs Health Care System, and a two-year fellowship at USC School of Pharmacy in HIV pharmacotherapy and translational research. She is credentialed by the American Academy of HIV Medicine. She was an Assistant Professor at Loma Linda University (LLU) School of Pharmacy. Dr. Lam joined Chapman University School of Pharmacy Department of Pharmacy Practice as one of the inaugural faculty members in 2014.

Dr. Lam had established her ambulatory care practice sites at the Desert AIDS Project Clinic, Riverside Neighborhood Health Center and Perris Family Care Center clinics. She received the Preceptor of the Year in Ambulatory Care from LLU School of Pharmacy. Dr. Lam currently practices in a multidisciplinary medical team treating HIV and HIV/HCV coinfected patients at the AltaMed Medical Group in Santa Ana. Dr. Lam received the American Association of Colleges of Pharmacy (AACP)/Walmart Scholars Award as facultymentor, and was recognized as Fellow of the California Society of Health-System Pharmacists (CSHP). She is currently a Director of the CSHP Foundation of Education and Research. She is actively involved with CSHP, Seminar and CPE planning committees. Dr. Lam is a member of the Rho Chi Academic Honor Society in Pharmacy and Phi Lambda Sigma Pharmacy Leadership Society.

Dr. Lam has authored multiple papers about HIV and Hepatitis C. She has been invited to speak on the topics of HIV, hepatitis C and other ambulatory care topics by nursing and pharmacy professional associations. She is also a reviewer for several journals on the topic of HIV and hepatitis infections.

Research Interests

Dr. Lam areas of research interest is in translational research in viral infections, and public health issues relating to the reduction of HIV stigma and the improvement of patient health outcomes and medication adherence. In addition, Dr. Lam is conducting research about natural products for various chronic conditions and viral infections.

Recent Creative, Scholarly Work and Publications

Lam JT, Marquez N, Nordt SP, Gutierrez MA. IPE Case Study and Guide – Infectious Diseases, Psychiatric Disorders and Substance Abuse: Viral Hepatitis, Substance Abuse, and Depression. In: Applied Therapeutics: The Clinical Use of Drugs, 11th ed., Lippincott Williams & Wilkins (Eds). Chapters 80,86,90. 2017. 

Lam JT, Holt C. Viral Hepatitis. In: Applied Therapeutics: The Clinical Use of Drugs, 11th ed., Zeind CS, Carvalho MG (Eds). Wolters Kluwer; 2017:1662-1692. 

Lam JT, Lynch A, Gutierrez MA. Systemic Lupus Erythematous. In: Applied Therapeutics: The Clinical Use of Drugs, 11th ed., Zeind CS, Carvalho MG (Eds). Wolters Kluwer; 2017:700-714. 

Gutierrez MA, Lam JT. Psychobiology and Psychopharmacology. In: Foundations of Psychiatric Mental Health Nursing, 8th ed., Halter MJ (Ed). Elsevier, St. Louis, Missouri; 2017:36-61. 

Lam J, Goad J. The burden of vaccine-preventable diseases in adults. Pharmacy Times, March 31, 2017.

Read More... 

Jordan R, Lam JT, Lyren A, et al. Actionable Patient Safety Solution (APSS) #3A: Medication Errors. Patient Safety Movement Foundation. February 2017.

Read More... 

Lam JT, Peters C, Barker S, et al. Actionable Patient Safety Solution (APSS) #3B: Antimicrobial Stewardship: The Role of A Pharmacy And The Microbiology Lab In Patient Safety. Patient Safety Movement Foundation. January 2017.

Read More... 

Lam JT, Barker S, Ramsay M, et al. Actionable Patient Safety Solution (APSS) #3C: Improve Prevention of Severe Hypoglycemia. Patient Safety Movement Foundation. January 2017.

Read More... 

Yang S, Lam JT, Sims N, et al. Actionable Patient Safety Solution (APSS) #3D: Pediatric Adverse Drug Events. Patient Safety Movement Foundation. February 2017.

Read More... 

Lam JT, Salazar L. New combination antiviral for the treatment of hepatitis C. Am J Health-Syst Pharm 2016;73(14):1042-1050. 

Lam JT, Yamaki J, Kayali Z. Advances in hepatitis C treatment: At the crossroads. J Nurse Pract. 2015;11:669-679. 

Lam JT. Hepatitis C: In The Crosshairs. Chapman Living Textbook. Orange County Register. January 5, 2015. (http://www.ocregister.com/articles/treatment-647184-hcv-infected.html). 

Gutierrez MA, Lam JT, Shaepper MA. Biological Basis for Understanding Psychiatric Treatments. In: Foundations of Psychiatric Mental Health Nursing, 7th ed. Varcarolis EM, Halter MJ (Eds). Elsevier, St. Louis, Missouri; 2013:37-62. 

Lam JT, Jacob S. Boceprevir: A new protease inhibitor for hepatitis C treatment. Am J Health-Syst Pharm. 2012;69:2135-2139.

Recent Creative, Scholarly Work and Publications
Lam JT, Lynch A, Gutierrez MA. Systemic Lupus Erythematosus. In: Applied Therapeutics: The Clinical Use of Drugs, 11th ed., Lippincott Williams & Wilkins (Eds.), 2017 (in press).
Gutierrez MA, Lam JT. Psychobiology and Psychopharmacology. In: Foundations of Psychiatric Mental Health Nursing, 8th Ed., Halter MJ (ed.), Elsevier, St. Louis, Missouri; 2017:36-61.
Lam, JT, Holt C. Viral Hepatitis. In: Applied Therapeutics: The Clinical Use of Drugs, 11th ed., Lippincott Williams & Wilkins (Eds.), 2017 (in press).
Lam J, Goad J. The burden of vaccine-preventable diseases in adults. Pharmacy Times, March 31, 2017.
Jordan R, Lam JT, Lyren A, et al. Actionable Patient Safety Solution (APSS) #3A: Medication Errors. Patient Safety Movement Foundation. February 2017.
Lam JT, Peters C, Barker S, et al. Actionable Patient Safety Solution (APSS) #3B: Antimicrobial Stewardship: The Role of A Pharmacy And The Microbiology Lab In Patient Safety. Patient Safety Movement Foundation. January 2017.
Lam JT, Barker S, Ramsay M, et al. Actionable Patient Safety Solution (APSS) #3C: Improve Prevention of Severe Hypoglycemia. Patient Safety Movement Foundation. January 2017.
Yang S, Lam JT, Sims N, et al. Actionable Patient Safety Solution (APSS) #3D: Pediatric Adverse Drug Events. Patient Safety Movement Foundation. February 2017.
Lam JT, Salazar L. New combination antiviral for the treatment of hepatitis C. Am J Health-Syst Pharm 2016;73(14):1042-1050.
Lam JT, Yamaki J, Kayali Z. Advances in hepatitis C treatment: At the crossroads. J Nurse Pract. 2015;11:669-679.
Lam JT. Hepatitis C: In The Crosshairs. Chapman Living Textbook. Orange County Register. January 5, 2015. (http://www.ocregister.com/articles/treatment-647184-hcv-infected.html).
Gutierrez MA, Lam JT, Shaepper MA. Biological Basis for Understanding Psychiatric Treatments. In: Foundations of Psychiatric Mental Health Nursing, 7th ed. Varcarolis EM, Halter MJ (Eds.), 2013:37-62.
Lam JT, Jacob S. Boceprevir: A new protease inhibitor for hepatitis C treatment. Am J Health-Syst Pharm. 2012;69:2135 – 39.